Drugs / KT095 CAR-T
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05515185 | Sep 2022 → Sep 2024 | neoplasm | The First People's Hospital of Lianyungang | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KT095 CAR-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05515185 ↗ |
| Modality | Cell therapy | “Autologous CAR-T cells” NCT05515185 ↗ |
| Route | Intravenous | “infused intravenously into subjects” NCT05515185 ↗ |